Watson’s Novel CAP Attracts Global Attention in the mRNA Industry

Watson’s Novel CAP Attracts Global Attention in the mRNA Industry

Background mRNA vaccines work by delivering mRNA that encodes for an antigen into human cells, where it is translated to produce the corresponding antigen protein, thereby inducing an effective immune response. The stability of mRNA, translation efficiency, and inherent immunogenicity are key to the success of mRNA as a therapeutic. The 5’ cap structure of